Search Results for ''

published presentations and documents on DocSlides.

Correctly modeling CD4 cell count in Cox regression analysis of HIV-positive patients
Correctly modeling CD4 cell count in Cox regression analysis of HIV-positive patients
by gagnon
Allison Dunning, M.S.. Research Biostatistician. W...
Correctly modeling CD4 cell count in Cox regression analysi
Correctly modeling CD4 cell count in Cox regression analysi
by myesha-ticknor
Allison Dunning, M.S.. Research Biostatistician. ...
1 Risk of progression to AIDS or death in relation to CD4 c
1 Risk of progression to AIDS or death in relation to CD4 c
by celsa-spraggs
Heiner C. Bucher for the Opportunistic Infections...
Joel E. Gallant, MD, MPH
Joel E. Gallant, MD, MPH
by kittie-lecroy
Professor of Medicine and Epidemiology. The Johns...
ROLE OF GBV
ROLE OF GBV
by obrien
- C AND HUMAN HERPES VIRUS COINFECTIONS IN AIDS D...
R. Palich *, M.  Veyri , M.-A.
R. Palich *, M. Veyri , M.-A.
by debby-jeon
Valantin. , A.-G. Marcelin, . F.Boue. ́, A. . Gu...
Sara
Sara
by test
Lodi. Harvard T.H. Chan School of Public Health. ...
HIV 2020:  Time for change
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
Randomized Trial of  Stopping or Continuing ART
Randomized Trial of Stopping or Continuing ART
by alexa-scheidler
among Postpartum Women with . Pre-ART CD4 . >....
A two-arm (proof of concept) randomised phase II trial Vorinostat plus a prime boost Vaccine
A two-arm (proof of concept) randomised phase II trial Vorinostat plus a prime boost Vaccine
by alexa-scheidler
A-899-0059-12977. Presented by Professor Sarah Fi...
A clinical score to
A clinical score to
by phoebe-click
prioritise . TB investigation among HIV+ adults i...
Prevalence of and Progression to Abnormal Non-Invasive Mark
Prevalence of and Progression to Abnormal Non-Invasive Mark
by luanne-stotts
Kapogiannis B. , Leister E, Siberry G, . Van Dyke...